Research Activities
Funds administered for research projects are managed separately from funds administered for education projects. Funds received by CureALL for support of research cannot be allocated to educational activities, unless the donor has made no restrictions on the use of the funds or has provided specific permission for reallocation of the funds. Likewise, funds received for support of education can be reallocated for support of research only under the same conditions.
|
May 2024 - Under CureALL Research Foundation's Health infrastructure initiative, we have just launched a $500,000 fundraising campaign in order to begin a clinical trial with the goal to make ketamine treatment affordable for veterans suffering from PTSD. Ketamine’s ability to dramatically reduce PTSD symptoms have been proven, but the effects do not always last a long time, requiring numerous maintenance infusions sometimes as many as one infusion every two weeks. Unfortunately, insurance companies do not cover ketamine infusions and can end up costing veterans between $5,000 and $10,000 annually to be treated, putting it out of reach for those who need it the most. CureALL Research Foundation is working with Reverie Mind to develop new treatment protocols and research ways for ketamine to have a longer lasting effect. Reduction in patient cost will result from reducing the number of ketamine infusions for the same or better results.
|
During the clinical trial, one-year of Ketamine infusion treatments will be provided free of charge to eligible veterans suffering from PTSD or Depression.
To help further reduce costs, in association with other research institutions and medical facilities, we will compile data to show insurance companies that there are real and sustainable benefits to ketamine infusion therapy for patients suffering from PTSD. Reduction in patient cost will result from infusions becoming a covered benefit by Medicare, Medicaid, VA, and commercial health insurance plans. Insurance companies need to know that this is worth covering and in many cases will reduce patient’s dependence on other expensive medications.
We are here to help people that don’t have options. Ketamine infusions should not be priced out of reach for the general population and with your help, we can improve thousands of veterans’ lives!
To help further reduce costs, in association with other research institutions and medical facilities, we will compile data to show insurance companies that there are real and sustainable benefits to ketamine infusion therapy for patients suffering from PTSD. Reduction in patient cost will result from infusions becoming a covered benefit by Medicare, Medicaid, VA, and commercial health insurance plans. Insurance companies need to know that this is worth covering and in many cases will reduce patient’s dependence on other expensive medications.
We are here to help people that don’t have options. Ketamine infusions should not be priced out of reach for the general population and with your help, we can improve thousands of veterans’ lives!